Home›Companies›Biotech & Pharma›Character Biosciences

Character Biosciences, Inc.

Updated Oct 29, 2026·Latest SEC filing Sep 17, 2025·Suggest an edit

About Character Biosciences

Character Biosciences is a private company based in Jersey City, New Jersey. It has reported $57,030,491 raised in two offerings on Form D since May 2025. Its chief executive is Cheng Zhang.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 2, 2025Sep 17, 2025$8,855,499of $19.6M target4$2.2MEquityRule 506(b)Form D ↗
Mar 20, 2025May 12, 2025$48,174,992of $110.5M target16$3.0MEquityRule 506(b)Form D ↗
Total, two offerings$57,030,491

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Character Biosciences's Form D filed Sep 17, 2025.

RS
Reut Shema
Director
VG
MA
Mayssa Attar
Director
JK
CZ
Cheng Zhang
CEO, CFO, and Secretary, director
PD
JH
Jason Hafler
Director
Nick Olsen
Nick Olsen
Director
Also a board member at Averna Therapeutics.

Sources

  1. SECCharacter Biosciences, Inc. filing history